Welcome to the e-CCO Library!

P697: De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Arenas, A.(1,2,3)*;Moreta, M.J.(4);Ordás, I.(1,4);Fernández-Clotet, A.(1,4);Caballol, B.(1,4);Gallego, M.(1,4);Vara, A.(1,4);Barastegui, R.(1,4);Giner, A.(1,4);Prieto, C.(1,4);Masamunt, M.C.(1,4);Ricart, E.(1,4);
Created: Friday, 14 July 2023, 11:12 AM
P697: Examining the regulatory role of epigenetic and transcriptomic alterations in anti-TNF treatment response and disease progression in patients with Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Lawal, O.(1);Stack, R.(2);Ciara, E.(2);Tosetto, M.(2);McDonnell, C.(1);Rodriguez-Sosa, A.(1);Yochum, G.(3);Koltun, W.(3);Boland, K.(4);Sheahan, K.(5);Doherty, G.(2);Das, S.(1);
Created: Friday, 11 February 2022, 3:56 PM
P697: Thiopurines vs. anti-TNFa for the prevention of postoperative recurrence in Crohn’s disease—a meta-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.M.J. Beelen1*, B. Oldenburg2, A.E. van der Meulen-de Jong3, C.I.J. Ponsioen4, G. Dijkstra5, M.J. Pierik6, F. Hoentjen7, N.K.H. de Boer8, N.S. Erler9, C.J. van der Woude1, A.C. de Vries1

Created: Thursday, 21 February 2019, 9:14 AM
P698 IBD patients equally tolerate bowel preparation but need higher doses of sedation during colonoscopy in comparison with a population screening programme: Results from a prospective, single-centre study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Bezzio1, P. Andreozzi2, M. Schettino1, I. Arena1, C. Della Corte1, M. Devani1, G. Manes1, B. Omazzi1, S. Saibeni1

Created: Thursday, 30 January 2020, 10:12 AM
P698: Early dose optimisation in non-responders to golimumab induction treatment for ulcerative colitis is supported by pharmacokinetic data
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Philip1, C. Marano2, J. Adedokun2, R. Melsheimer3, F. Cornillie4*

Created: Thursday, 21 February 2019, 9:14 AM
P698: Mapping field cancerisation and clonal evolution in IBD colons with dysplasia and colorectal cancer
Year: 2022
Source: ECCO'22
Authors: Yalchin, M.(1);Curtius, K.(2);Nowinski, S.(3);Moorghen, M.(1);Kimberley, C.(3);Smith, K.(3);Baker, A.M.(3);Al-Bakir, I.(3);Mossner, M.(3);Nadhamuni, V.(3);Hart, A.(1);Graham, T.(3);
Created: Friday, 11 February 2022, 3:56 PM
P698: Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Sartini*1, R. Solimando2, A. Curatolo1, M. C. Verga1, A. Bertani1, M. Di Girolamo3, A. Merighi2, E. Villa1

Created: Friday, 22 February 2019, 9:41 AM
P698: Role of an exclusion diet (reduced disaccharides, saturated fats, emulsifiers, red and ultraprocessed meats) in maintaining the remission of chronic inflammatory bowel diseases in adults
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Preda, C.M.(1)*;Istratescu, D.(2);Manuc, T.(2);Nitescu, M.(3);Louis, E.(4);Manuc, M.(2);Stroie, T.(2);Diculescu, M.(2);
Created: Friday, 14 July 2023, 11:12 AM
P698: The risk of developing subsequent immune mediated inflammatory diseases: a retrospective matched cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Panaccione R.*1, Aletaha D.2, Davis M.3, Johnson S.3, Skup M.4, Garg V.4

Created: Wednesday, 20 February 2019, 10:36 AM
P699 The concordance of Short Form-36 Health Survey scores with Mayo scores in the tofacitinib ulcerative colitis clinical programme
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.C. Dubinsky1, A.G. Bushmakin2, J.C. Cappelleri2, J. Woolcott3, P. Sharma4, E. Maller3, L. Salese3, A. Armuzzi5

Created: Thursday, 30 January 2020, 10:12 AM
P699: Faecal microbiota transplantation as treatment for recurrent clostridium difficile infections: a single-centre experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Caenepeel*1, A. Schroë1, K. Van den Broeck2, M. Ferrante1,2, S. Vermeire1,2

Created: Friday, 22 February 2019, 9:41 AM
P699: Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Marshall J.K.*1,2, Narula N.1, Lebovic G.3,4, Millson B.5, Charland K.5, Sung M.5, Gaetano T.6, McHugh K.6, Latour M.6, Laliberte M.-C.6

Created: Wednesday, 20 February 2019, 10:36 AM
P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT Study
Year: 2022
Source: ECCO'22
Authors: Chun, J.(1);Suji, K.(2);Kwang Sung, A.(3);Soo Kyung, P.(4);Sangsoo, K.(2);Dong Il, P.(4);
Created: Friday, 11 February 2022, 3:56 PM
P699: Radiologic response reduces the risk of small-bowel surgery in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Hallé1*, M. Azahaf1, N. Duveau2, M. Nachury1, J. Branche1, R. Gerard1, P. Wils1, P. Desreumaux1, O. Ernst1, B. Pariente1

Created: Thursday, 21 February 2019, 9:14 AM
P699: Ustekinumab therapy after biologic failure in patients with Crohn's Disease – A real-world single centre experience​​
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Majumder, S.(1,2,3)*;Bazarova, A.(4);Lorenzo Parigi, T.(1,3); Love , M.(5);Davis , J.(3);Ghosh, S.(6); Iacucci , M.(1,3,7);N. Shivaji, U.(1,3,7);
Created: Friday, 14 July 2023, 11:12 AM
P700 Effect of vitamin D in disease activity score and clinical relapse in patients with inflammatory bowel disease: A systematic review and meta-analysis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Guzman1, O. Samson1, J.P. Segal2, J.K. Limdi3, B. Hayee4

Created: Thursday, 30 January 2020, 10:12 AM
P700: A high CRP before surgery and early medical prophylaxis predict postoperative endoscopic Crohn’s disease recurrence
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Sooben1, L. Thin1*, S. Picardo2, B. Mackinnon3, J. Ryan4, M.H. Wallace4,5

Created: Thursday, 21 February 2019, 9:14 AM
P700: Epidemiology of genital lymphoedema as the initial presentation of paediatric Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Jagger F.*1, Dall A.2, Henderson P.2, Wilson D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P700: Perceptions towards established and emerging dietary therapies for Crohn's disease management among the adult patients: results from a questionnaire survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jatkowska, A.(1);White, B.(1);Jaskolski, P.(1);Brownson, E.(2);Clowe, J.(2);Seenan, J.P.(2);Gerasimidis, K.(1)*;MacDonald, J.(2);
Created: Friday, 14 July 2023, 11:12 AM
P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Devarakonda*1, I. Arnott2, J. Satsangi3

Created: Friday, 22 February 2019, 9:41 AM